ARCHIVES

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

Cost To Oncologist For Enrolling a Patient On Trial About $2,000, ASCO Survey Finds

June 11, 1999

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program

July 23, 1999